Literature DB >> 7396593

Familial hyperuricemia and renal disease.

P U Massari, C H Hsu, R V Barnes, I H Fox, P W Gikas, J M Weller.   

Abstract

Information on a familial syndrome of hyperuricemia and renal disease with or without gout was obtained on 33 of 41 blood relatives: Nine had renal disease; abnormalities of the urinary sediments were minimal; serum uric acid levels were elevated in seven and were not measured in two. Hyperuricemia was noted in three additional family members without evidence of renal disease. Goulty arthritis (three patients) did not precede renal disease. One individual had hyperuricosuria. The following erythrocyte purine enzyme levels were normal: adenine phosphoribosyltransferase, hypoxanthine-guanine phosphoribosyltransferase, phosphoribosylpyrophosphate, synthetase, adenosine deaminiase, and purine nucleoside phosphorylase. Renal biopsy specimens showed focal global and segmental sclerosis of glomeruli, occasional hypercellularity, foci of atrophic tubules, chronic interstitial inflammation, and folding and wrinkling of glomerular basement membrane without electron-dense deposits. There were no immunofluorescent abnormalities.

Entities:  

Mesh:

Year:  1980        PMID: 7396593

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy.

Authors:  T C Hart; M C Gorry; P S Hart; A S Woodard; Z Shihabi; J Sandhu; B Shirts; L Xu; H Zhu; M M Barmada; A J Bleyer
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

2.  Familial gout and renal failure.

Authors:  D J Warren; H A Simmonds; T Gibson; R B Naik
Journal:  Arch Dis Child       Date:  1981-09       Impact factor: 3.791

3.  Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter.

Authors:  M S Lipkowitz; E Leal-Pinto; J Z Rappoport; V Najfeld; R G Abramson
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family.

Authors:  N Yokota; H Yamanaka; Y Yamamoto; S Fujimoto; T Eto; K Tanaka
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 5.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 6.  Galectin 9 is the sugar-regulated urate transporter/channel UAT.

Authors:  Michael S Lipkowitz; Edgar Leal-Pinto; B Eleazar Cohen; Ruth G Abramson
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

7.  Clinical and family studies in Hungarian patients with gout.

Authors:  M Mituszova; A Judák; G Poór; E Gyódi; V Stenszky
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

8.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

Review 9.  New developments in the epidemiology and genetics of gout.

Authors:  Raihana Zaka; Charlene J Williams
Journal:  Curr Rheumatol Rep       Date:  2006-06       Impact factor: 4.686

10.  Prevention of renal damage by treating hyperuricemia.

Authors:  Azar Nickavar
Journal:  Int J Prev Med       Date:  2013-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.